SIRT3 and melanoma: We found that SIRT3 inhibition significantly modulates genes related to glycolysis, gluconeogenesis, Krebs cycle and Pentose phosphate pathway, suggesting that inhibition of SIRT3 hampers cellular metabolism, which eventually hinders the proliferative potential of melanoma cells.